MiNK Therapeutics, Inc. (INKT)

SEC filing

MiNK Therapeutics, Inc.

INKT · CIK 1840229

4 · Oct 14, 2026 · Director, Chief Executive Officer Buell Jennifer sold 6,938 shares at $10.56/share ($73,265); exercised options for 46.38K shares

Director, Chief Executive Officer Buell Jennifer sold 6,938 shares at $10.56/share ($73,265); exercised options for 46.38K shares

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).